April 20, 2026 • United States
US-based biomaterials company MycoWorks, known for its mycelium-derived leather alternative, Reishi, has undergone a major restructuring following financial difficulties that culminated in insolvency in late 2025, with its assets subsequently acquired by investment firm DFX Corp.